{"disease":{"id":"draf-i-or-iia","name":"draf i or iia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06668844","title":"Endoscopic Direct \"Draf IIa\" (Carolyn's Window Approach) Versus Endoscopic Angled \"Draf IIa\"Approach in Chronic Rhinosinusitis With Frontal Sinus Affection ( A Comparative Study ).","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":68,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05979662","title":"Endoscopic Frontal Sinus Surgery Draf III in Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Ibrahim Talal Elshamy","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}